These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7170822)

  • 21. Pharmacokinetics and bioavailability of percutaneous ibuprofen.
    Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR
    Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased bioavailability of digoxin due to antacids and kaolin-pectin.
    Brown DD; Juhl RP
    N Engl J Med; 1976 Nov; 295(19):1034-7. PubMed ID: 972657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
    Alvisi V; Longhini C; Bagni B; Portaluppi F; Ruina M; Fersini C
    Arzneimittelforschung; 1979; 29(7):1047-50. PubMed ID: 582997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum-digoxin concentrations with a new digoxin derivative, beta-methyl-digoxin.
    Härtel G; Manninen V; Melin J; Apajalahti A
    Ann Clin Res; 1973 Apr; 5(2):87-90. PubMed ID: 4748756
    [No Abstract]   [Full Text] [Related]  

  • 26. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability of digoxin: some pitfalls and problems.
    Keller F; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):549-56. PubMed ID: 23358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bioavailability of digoxin and beta-methyl-digoxin in patients with liver and gastro-intestinal diseases ].
    Hess T; Bütler A; Stucki P
    Wien Klin Wochenschr; 1982 May; 94(10):251-8. PubMed ID: 7123952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absolute bioavailability of a new high dose methylprednisolone tablet formulation.
    Groenewoud G; Hundt HK; Luus HG; Müller FO; Schall R
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):652-4. PubMed ID: 7881703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
    Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
    Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological availability of digoxin and beta-methyl-digoxin administered in the fasting state or after meals].
    Hess T; Krähenbühl A; Luisier J; Weiss M
    Schweiz Med Wochenschr; 1981 Sep; 111(39):1434-40. PubMed ID: 7291961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence (author's transl)].
    Gastauer R; Eltze M; Pabst J
    Arzneimittelforschung; 1979; 29(5):754-7. PubMed ID: 582973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
    Bodem G; Ochs H; Hahn E; Dengler HJ
    Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
    [No Abstract]   [Full Text] [Related]  

  • 37. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dose on bioavailability of oral digoxin.
    Ochs HR; Bodem G; Greenblatt DJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):53-5. PubMed ID: 7461024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
    Hatorp V; Oliver S; Su CA
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.